These results suggest that dephosphorylation of Pyrin is sufficient to trigger inflammasome activation in monocytes from FMF patients while a PKC‐independent mechanism limits IL‐1β release in HD monocytes. This evidence concerns the gene PRRT2 and Huntington disease.